Skip to content
🧬 New: 3 PDRN clinical studies added this weekπŸ”¬ 120+ PDRN products compared β€” find your matchπŸ“© Free weekly PDRN research digest β€” subscribe below
PDRN Care
WikiSkin Biology

Langerhans Cells

Dr. Sarah Chen

Dr. Sarah Chen

PhD, Molecular Biology

5 minJune 20, 2025Updated April 21, 2026
Definition

A Langerhans cell is a tissue-resident dendritic cell of hematopoietic origin that occupies the suprabasal layers of the epidermis.

Langerhans cells (LCs) are a specialized population of dendritic cells that reside within the epidermis, forming the skin's first line of immunological defense. Discovered by Paul Langerhans in 1868, these bone marrow-derived antigen-presenting cells constitute approximately 2--4% of all epidermal cells and maintain a dense network of dendritic processes that survey the keratinocyte microenvironment for foreign antigens, pathogens, and danger signals .

Definition

A Langerhans cell is a tissue-resident dendritic cell of hematopoietic origin that occupies the suprabasal layers of the epidermis. Langerhans cells are uniquely identified by the expression of langerin (CD207), a C-type lectin receptor that mediates antigen capture and drives the formation of Birbeck granules -- tennis racket-shaped cytoplasmic organelles that are pathognomonic for this cell type . As professional antigen-presenting cells (APCs), Langerhans cells bridge innate and adaptive immunity in the skin, capturing antigens at the epidermal surface and migrating to regional lymph nodes to present processed peptides to naive T cells.

Structure and Distribution

Dendritic Morphology

Langerhans cells are characterized by extensive dendritic processes that interdigitate between surrounding keratinocytes, creating a quasi-continuous network that blankets the epidermis. This stellate morphology maximizes the surface area available for antigen sampling, enabling Langerhans cells to detect pathogens and environmental insults across the entire epidermal surface without requiring high cell density . The dendritic processes are dynamic and can extend or retract in response to inflammatory signals and microbial stimuli.

Epidermal Localization

Langerhans cells are positioned primarily in the suprabasal layers of the epidermis (stratum spinosum), though their dendrites extend into the stratum granulosum and occasionally reach the stratum corneum. Their density varies by anatomical site, with the highest concentrations found on the face, neck, and genital mucosa (700--1,000 cells per mm2) and lower densities on the trunk and extremities . This distribution correlates with areas of greatest environmental exposure and barrier vulnerability.

Birbeck Granules

The hallmark ultrastructural feature of Langerhans cells is the Birbeck granule, a pentalaminar, rod-shaped organelle with a characteristic "tennis racket" or "zipper-like" morphology. Birbeck granules are formed through langerin-mediated endocytosis and are involved in antigen processing and routing to the endosomal compartment . Their presence on electron microscopy remains the definitive criterion for identifying Langerhans cells in tissue sections.

Function

Antigen Capture and Processing

Langerhans cells continuously sample the epidermal microenvironment through multiple mechanisms: macropinocytosis (bulk fluid uptake), receptor-mediated endocytosis (via langerin, mannose receptors, and Fc receptors), and phagocytosis of particulate antigens and apoptotic cells. Captured antigens are internalized and processed into peptide fragments within the endosomal-lysosomal compartment, then loaded onto MHC class I and class II molecules for presentation .

Migration and T-Cell Activation

Upon encountering danger signals -- including pathogen-associated molecular patterns (PAMPs), cytokines such as TNF-alpha and IL-1beta from keratinocytes, and damage-associated molecular patterns (DAMPs) -- Langerhans cells undergo a maturation program. They upregulate co-stimulatory molecules (CD80, CD86), increase MHC expression, and detach from the epidermal network. Mature Langerhans cells then migrate through the dermis and afferent lymphatics to the paracortical T-cell zones of draining lymph nodes, where they present antigen-MHC complexes to naive T cells, initiating adaptive immune responses .

Immune Tolerance

Beyond their role in activating protective immunity, Langerhans cells are critically involved in maintaining peripheral immune tolerance. Under steady-state conditions, Langerhans cells present self-antigens and innocuous environmental antigens in the absence of co-stimulatory signals, promoting the differentiation of regulatory T cells (Tregs) and deletion of autoreactive T-cell clones . This tolerogenic function prevents inappropriate immune responses to commensal microorganisms and harmless environmental molecules -- a failure of which contributes to allergic contact dermatitis and other hypersensitivity disorders.

UV and Environmental Damage

UV-Induced Depletion

Ultraviolet radiation is the most well-characterized extrinsic factor that damages Langerhans cell populations. Acute UV exposure induces Langerhans cell apoptosis, triggers premature migration from the epidermis, and impairs the capacity of surviving cells to present antigen effectively. UVB radiation is particularly destructive, reducing epidermal Langerhans cell density by 50--90% within 24--72 hours of a single erythemogenic dose . This UV-induced immunosuppression is thought to contribute to the increased susceptibility to skin infections and cutaneous malignancies following chronic sun exposure.

Pollution and Oxidative Stress

Environmental pollutants -- including particulate matter (PM2.5), polycyclic aromatic hydrocarbons, and ozone -- compromise Langerhans cell function through oxidative damage and disruption of the epidermal barrier. Pollutant-induced oxidative stress damages Langerhans cell membranes, impairs antigen-processing machinery, and alters cytokine profiles, skewing immune responses toward chronic inflammation rather than effective pathogen clearance .

Langerhans cell density and function decline progressively with age. Aged skin contains 20--50% fewer Langerhans cells than young skin, and the remaining cells exhibit reduced dendritic complexity, impaired migration kinetics, and diminished antigen-presenting capacity. This age-related decline in cutaneous immune surveillance is associated with increased infection susceptibility, impaired wound healing, and higher incidence of skin cancers in elderly populations .

PDRN Connection

PDRN (polydeoxyribonucleotide) influences Langerhans cell biology primarily through its activation of the adenosine A2A receptor, which modulates the inflammatory microenvironment in which these immune sentinel cells operate .

A2A-Mediated Immune Modulation

The adenosine A2A receptor is expressed on multiple immune cell populations, including dendritic cells. PDRN's activation of this receptor elevates intracellular cAMP, which promotes an anti-inflammatory phenotype -- reducing the excessive production of pro-inflammatory cytokines (TNF-alpha, IL-1beta, IL-6) that can drive Langerhans cell dysfunction and premature depletion . By dampening the inflammatory milieu, PDRN helps preserve Langerhans cell viability and function during periods of cutaneous stress, such as following UV exposure or dermatological procedures.

Supporting Langerhans Cell Recovery

After UV damage or procedural trauma depletes epidermal Langerhans cell populations, recovery depends on two processes: repopulation from local precursors and recruitment of monocyte-derived replacements from the bloodstream. Both processes require an appropriately regulated inflammatory environment -- excessive inflammation impairs precursor differentiation and disrupts the chemokine gradients necessary for monocyte homing to the epidermis. PDRN's ability to resolve inflammation and promote orderly tissue repair creates conditions favorable for Langerhans cell repopulation .

Anti-Inflammatory Effects on Skin Immunity

By modulating the broader anti-inflammatory pathways in the skin, PDRN indirectly supports the balance between immune activation and tolerance that Langerhans cells maintain. In inflamed or damaged skin, uncontrolled cytokine release can shift Langerhans cells toward an overly stimulatory phenotype, contributing to hypersensitivity reactions and chronic inflammation. PDRN's anti-inflammatory action helps restore the regulatory equilibrium, allowing Langerhans cells to resume their normal dual role of pathogen defense and immune tolerance .

  • Keratinocyte -- The predominant epidermal cell that signals Langerhans cells through cytokine release
  • Anti-Inflammatory Pathways -- Mechanisms through which PDRN modulates the immune environment around Langerhans cells
  • Cytokines -- Signaling molecules that regulate Langerhans cell maturation, migration, and function
  • Wound Healing -- Process in which Langerhans cell recovery contributes to restored immune surveillance
  • Polydeoxyribonucleotide -- The active compound whose A2A receptor activation supports Langerhans cell preservation
  • Oxidative Stress -- Environmental damage pathway that compromises Langerhans cell function
Reviewed by Dr. Min-Ji Park, MD, Board-Certified Dermatologist

References

  1. [1]
    Deckers J, Hammad H, Hoste E. Langerhans Cells: Sensing the Environment in Health and Disease. Front Immunol. 2018;9:93. doi:10.3389/fimmu.2018.00093
  2. [2]
    Merad M, Ginhoux F, Collin M. Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells. Nat Rev Immunol. 2008;8(12):935-947. doi:10.1038/nri2455
  3. [3]
    Kaplan DH. In vivo function of Langerhans cells and dermal dendritic cells. Trends Immunol. 2010;31(12):446-451. doi:10.1016/j.it.2010.08.006
  4. [4]
    Schwarz A, Schwarz T. UVR-Induced Regulatory T Cells Switch Antigen-Presenting Cells from a Stimulatory to a Regulatory Phenotype. J Invest Dermatol. 2010;130(7):1914-1921. doi:10.1038/jid.2010.59
  5. [5]
    Squadrito F, Bitto A, Irrera N, et al.. Pharmacological Activity and Clinical Use of PDRN. Curr Pharm Des. 2017;23(27):3948-3957. doi:10.2174/1381612823666170516153716
  6. [6]
    Gallo L, Murdaca G, Betto E, et al.. PDRN: Regenerative and Anti-inflammatory Properties for Post-Procedural Skin Recovery. Int J Mol Sci. 2023;24(8):7183. doi:10.3390/ijms24087183
ShareTwitterLinkedIn

Search

Search across products, blog posts, wiki articles, and more.